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Abstract Store-regulated Ca2+ entry represents a major 
mechanism for Ca + influx in non-excitable cells although many 
details remain to be evaluated including the identification of 
cation entry channels. Recently human homologues of the 
Drosophila proteins TRP and TRPL, have been described 
(TRPC1, TRPC1A, HTRP1) and suggested as candidate cation 
channels. In this study we sought to examine if the producers of 
blood platelets, megakaryocytic cells (using the cell lines 
MEG01, DAMI, HEL), expressed these genes. RNA was 
prepared from the cell lines and platelets and converted to 
cDNA. The cDNA was then subjected to 30-35 cycles of PCR 
using gene specific primers for TRPC1-3. PCR products of the 
expected sizes were observed for all three TRPC genes in the 
three cell lines. Direct sequencing confirmed their identity. 
Additionally for TRPC1, a larger species, and for TRPC2, a 
smaller species was detected in all three cell lines with sequencing 
revealing the fragments to contain TRPC sequence, suggesting 
that they were either products of alternative splicing events or 
from closely related genes. These results suggest that TRPC 
genes are expressed in megakaryocytic cell lines and that the 
TRPC proteins may play a role in mediating cation influx in both 
megakaryocytes and platelets. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The elucidation of Ca2+ influx mechanisms in non-excitable 
cells represents a major challenge. In platelets Ca2+ influx may 
occur via three main mechanisms. Firstly activation of a re-
ceptor operated cation channel (ROC) by agonists such as 
ADP, may lead to very rapid Ca2+ entry with studies using 
the stopped flow technique measuring millisecond time inter-
vals confirming that ADP induces Ca2+ entry without a meas-
urable time delay [1]. However, with most agonists acting via 
G protein linked receptors or through tyrosine phosphoryla-
tion linked mechanisms, Ca2+ influx is slower than that in-
duced by an ROC mechanism and is thought to be regulated 
by the filling state of the intracellular stores (store-regulated 
or capacitative Ca2+ entry [2]). With this mechanism the sec-
ond messenger inositol 1,4,5-trisphosphate (IP3) serves to re-
lease Ca2+ from intracellular stores, which in turn leads to the 
generation of a (presently) ill-defined signal that opens Ca2+ 
channels in the plasma membrane. Thirdly Ca2+ entry may 
occur as a consequence of the action of second messengers 
acting directly on the plasma membrane as has been demon-
strated with Ca2+ and inositol 1,3,4,5-tetrakisphosphate in 
endothelial cells [3]. 
There is evidence for multiple types of Ca2+ entry channels 
in non-excitable cells and work towards the identification of 
members of this family has attracted considerable interest (for 
a short review see [4]). In Drosophila the trp and trpl genes 
have been identified to code for cation channels (TRP and 
TRPL) which can be activated by store depletion and agonists 
acting at G-protein linked receptors (respectively) [5-7]. The 
expressed TRP channel shows a higher selectivity for Ca2+ 
than TRPL and has some characteristics similar to the store 
regulated Ca2+ current identified in mast cells [6,8,9]. These 
studies have led to the search for human homologues of TRP 
and TRPL proteins that may represent candidate plasma 
membrane Ca2+ channels. Recently, two groups have reported 
two cDNA stretches coding for proteins termed TRPC1 [10] 
and Htrp-1 [11] whose primary structure shares approx. 37-
40% sequence identity to TRP and TRPL. The cDNAs for 
both TRPC1 and Htrp-1 are identical in large parts except for 
variations in the region coding for the amino terminal part of 
the proteins. Sequences for two transcripts from highly ho-
mologous genes (TRPC2 and TRPC3) have also been re-
ported, suggesting other members within this family 
[10,11a]. A splice variant of the Htrp-1, termed TRPC1A 
has been functionally expressed in CHO cells and shown to 
be activated by IP3 and thapsigargin [12] and Htrp-3 ex-
pressed in COS cells also shows capacitative Ca2+ entry [1 la]. 
As Ca2+ entry forms an essential component of the activa-
tion pathway in platelets and a component of Ca2+ entry is 
mediated by store depletion, we sought to examine whether 
platelets and megakaryocytes contain transcripts from any of 
the known TRPC genes. For the latter we have used leukae-
mic cell lines that have phenotypic properties of megakaryo-
cytic precursors namely MEG01, DAMI and HEL cells. We 
report that all three cells lines express mRNA transcripts de-
rived from TRPC1-3 genes with the possibility of products of 
alternative splicing events for TRPC1 and TRPC2. 
2. Materials and methods 
2.1. Cell culture and platelet preparation 
The DAMI cell line was obtained from Dr. R. Handin (Boston, 
MA, USA), HEL and MEG01 were obtained from Dr. S.P. Watson 
(Oxford, UK) and Dr. G. Périès (Paris, France). The cells were grown 
in RPMI 1640 plus 10% fetal calf serum. Cells were harvested by 
centrifugation and washed once in PBS before extraction of RNA. 
Platelets were isolated from fresh human blood and washed exactly as 
described previously [13]. 
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2.2. Preparation of RNA 
Total RNA was isolated according to the principle of Chomczynski 
and Sacchi [14] but using RNAzol reagent (Tel-Test, Inc., Friends-
wood, USA) according to the manufacturer's instructions. Briefly, 
cells were lysed in 2 ml guanidine thiocyanate-phenol-chloroform sol-
ution. Following centrifugation at lOOOOXg, the RNA-containing 
aqueous phase was removed and the total RNA precipitated using 
1 vol. isopropanol. After one wash in 70% ethanol and resuspension, 
RNA was directly used for cDNA synthesis. 
2.3. cDNA synthesis and PCR amplification (RT-PCR) 
6 ug total RNA were used for each reverse transcription reaction 
using the 'ready to go' T-Primed First strand Kit (Pharmacia, Uppsa-
la, Sweden). cDNA synthesis was carried out at 45°C. Aliquots (1/10 
to 1/6 of the reaction mixture) of cDNA were then used directly as 
template in subsequent PCR reactions which employed AmpliTaq 
Gold polymerase (Roche Molecular Systems, Inc., Branchburg, 
USA) and its 10 X PCR buffer containing 15 mM MgCl2. Cycling 
conditions were: 1 min at 94°C, 1 min at 55°C or 59°C, 1 min at 
72°C for the number of cycles specified in the Results section. The 
initial denaturing step was 12 min at 94°C, the final extension was 10 
min at 72°C. Oligonucleotide primers used were: for TRPCl, trpclf 
and trpclr; for TRPC2, trpc2f and trpc2r; for TRPC3, trpc3f and 
trpc3r; the sequence and location of these oligonucleotides are given 
in Table 1. Oligonucleotide primers for amplification of glyceralde-
hyde 3-phosphate dehydrogenase (G3PDH) mRNA were obtained 
from Clontech (Palo Alto, CA, USA) and used according to the 
manufacturer's instructions. 
2.4. Analysis of PCR products 
PCR-amplified fragments were visualised by ethidium bromide 
staining following agarose gel electrophoresis. PCR products were 
excised from agarose gels and purified using the Geneclean II kit. 
Where stated sequencing of the purified fragments was carried out 
by the method of Sanger et al. [15] using a sequenase PCR product 
sequencing kit (USB, Cleveland, OH, USA). 
3. Results 
In order to investigate the presence of TRPC transcripts in 
human megakaryocytic cell lines, an RT-PCR based strategy 
was employed. Oligonucleotide primers were designed so as to 
bind specifically to either TRPCl, TRPC2 or TRPC3 cDNA 
(regions of strong homology were avoided) and to generate 
PCR products of different sizes. 
Total RNA was prepared from the three human megakar-
yocyte cell lines (DAMI, HEL and MEG01). Following re-
verse transcription with oligo dT primer, aliquots of each 
cDNA mixture were subjected to 35 cycles of PCR using 
gene specific primers (see Table 1). Subsequent agarose gel 
electrophoresis revealed PCR products of the expected size 
for each of the three TRPC transcripts (427 bp for TRPCl, 
343 bp for TRPC2 and 304 bp for TRPC3; Fig. 1A), suggest-
ing that all three genes are expressed in these cell lines. In 
identical PCR reactions which contained 100 ng genomic 
DNA (instead of cDNA) as template, no products were ob-
Fig. 1. Detection of PCR products derived from transcripts of 
TRPC1-3 genes in megakaryocytic cell lines MEG01, DAMI and 
HEL. Shown are ethidium bromide stained agarose gels. (A) Prod-
ucts after 35 cycles of PCR with primers for TRPC 1-3. Ma, size 
marker (c|)X174///aeIII); M, MEG01; D, DAMI; H, HEL. (B) 
Products after 30 cycles of PCR with DAMI cDNA using TRPC1-
3 primers (labelled 1-3). (-) Negative PCR control (no cDNA). 
served (data not shown), excluding the possibility that the 
bands were derived from chromosomal contamination. Unex-
pectedly, additional PCR products were observed for both 
TRPCl and TRPC2 (and a very faint additional band for 
TRPC3). When PCR reactions were performed under more 
stringent conditions (59°C annealing temperature) and for 
only 30 cycles, a prominent additional band for both 
TRPCl and TRPC2 was still present (slightly above TRPCl 
and slightly below TRPC2, respectively; Fig. IB shows typical 
results obtained with the DAMI cell line, similar results were 
obtained with MEG01 and HEL), raising the possibility that 
these bands did not result from PCR artefacts but could in-
stead represent either alternatively processed TRPC tran-
scripts or transcripts from novel homologous genes. 
The PCR products of the expected size were isolated and 
purified by the Geneclean II kit for further characterization. 
Direct sequence analysis confirmed their identity as wild-type 
TRPC 1-3 transcripts (data not shown). This demonstrates 
that all three genes are transcribed in human megakaryocytes 
and suggests that several store-operated ion channels may be 
involved in megakaryocyte/platelet Ca2+ homeostasis. Fur-
thermore, these findings indicate that the expression of the 
not yet fully characterised TRPC2 (pseudo) and TRPC3 genes 
is not restricted to those cell types from which the respective 
cDNA clones had been derived (fetal liver/spleen and fetal 
brain, respectively). 
In addition, the major two aberrantly sized types of PCR 
product, presumed to be derived either from the TRPC genes 
or from homologous genes, were isolated. Direct sequencing 
revealed that both the larger product formed with the TRPCl 
Table 1 









5 ' -ACTCTGGTATGAAGGGTTGGA-3 ' 
5'-GGTATCATTGCTTTGCTGTTC-3' 











f, forward; r, reverse; location refers to the sequences deposited in GenBank accession numbers: X89066 (TRPCl), X89067 (TRPC2) and X89068 
(TRPC3). 
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spi. sile cons: AGGTAAGT CAG 
wild-type: GAAGATTGAG\GATGATGCTGACGTGGAGTGGACGT7TGCTCGCTCCAAG\CTGT ATCTGTJCTACTYCfiGÄlfiAG 
variant: GAAGAITGAGCTGTATCTGTrCTACTTCtTGAbAG 
Fig. 2. Sequence comparison of TRPC2 wild-type and variant PCR products derived from DAMI cell cDNA. The additional 39 bp in the 
wild-type transcripts are shown in italics and the premature stop codon is boxed in both sequences. Since the nucleotides in this region exhibit 
some similarity to splice sites, consensus sequences are given above for comparison (invariant dinucleotides in bold). 
primers and the smaller product formed with the TRPC2 pri-
mers contained TRPC1 and TRPC2 sequence (respectively). 
The smaller TRPC2 fragment lacked 39 bp (nucleotides 461-
499 of Genbank sequence accession no. X89067) of the wild-
type sequence (Fig. 2) and had most likely been generated via 
alternative splicing (splice site consensus sequences are shown 
in Fig. 2 for comparison with the relevant TRPC2 nucleo-
tides). The aberrantly sized TRPC1 PCR product also con-
tained a stretch of wild-type sequence but linked to additional 
nucleotides of unknown origin (data not shown); it is not 
known whether this transcript species represents a TRPC1 
splice variant or is derived from mRNA of a homologous 
gene. Both possibilities are currently under investigation. 
Although differentiated platelets cannot produce mRNA 
themselves, transcripts of several genes active at the megakar-
yocyte stage can be detected in human platelets. In order to 
establish whether TRPC transcripts were also present, total 
platelet RNA (representing stored rather than freshly tran-
scribed mRNAs) was isolated and converted into cDNA. 
PCR reactions employing 40 amplification cycles failed to 
detect any correctly sized TRPC cDNA (Fig. 3). PCR using 
the TRPC2 primers did generate two products, however, as 
these were markedly different from the expected sizes they 
were not characterised further. From the same RNA prepa-
ration, cDNA derived from the housekeeping gene G3PDH, 
employed as a positive control, was detected (Fig. 3) demon-
strating that the RNA quality had been adequate. 
4. Discussion 
The identification of human genes encoding potential store-
operated ion channels [10] will now provide the opportunity 
to analyse the role of the corresponding proteins in various 
cell types. The finding that TRPC1A expressed in CHO cells 
can be activated by thapsigargin or IP3 is strong evidence that 
these proteins play an important role in receptor mediated 
Ca2+ entry. As a first step to assess the function of such 
proteins in cells of the megakaryocyte lineage, we studied 
the expression of the three known human TRPC genes in 
megakaryocyte cell lines. RT-PCR analysis revealed that tran-
scripts from all three genes were present in all three cell lines, 
suggesting that the respective proteins may be involved in 
signalling events both in megakaryocytes and in platelets. 
Northern blot analysis has previously demonstrated high-
level expression of TRPC1 in heart, brain, testes and ovary, 
and lower levels of TRPC1 transcripts in all other human 
tissues tested with the exception of liver [10,11]. However, 
homologous TRPC1 mRNA in mouse liver could be detected 
by RT-PCR analysis, suggesting that low levels of TRPC1 
transcripts may also be found in human liver. This is consist-
ent with our finding that TRPC1 mRNA could be amplified 
with 30 PCR cycles from human hepatoma cell cDNA (data 
not shown). The presence of TRPC1 mRNA in megakaryo-
cytic cell lines reported here lends further support to the no-
tion that TRPC1 is ubiquitously expressed in human cells, 
albeit at cell type specific levels. We have shown here that 
both TRPC2 and 3 are transcribed in cells other than fetal 
liver/spleen and fetal brain, respectively, from which the orig-
inal cDNA clones had been isolated. It therefore appears that 
all three human TRPC genes may be ubiquitously transcribed. 
Wes et al. [10] have reported that the TRPC2 cDNA sequence 
contains a stop codon in a position corresponding to residue 
690 in TRPC1 (Fig. 2) and may therefore represent an ex-
pressed pseudogene. 
The relative levels of transcription from the three genes are 
difficult to assess without the use of sophisticated internal 
PCR controls. Based on the comparison of band strengths, 
we suggest that the three genes are expressed at similar levels 
in these cell lines. With each of the specific primer pairs used, 
distinct RT-PCR products were observed : an additional band 
was reproducibly observed with TRPC1 and TRPC2 specific 
primers (Fig. IB). DNA sequence analysis of these bands 
confirmed their origin as derived from the respective TRPC 
genes. We suggest the TRPC2 derived transcript represents an 
alternative splicing product which remains in frame and re-
tains the stop codon (Fig. 2). The elucidation of the TRPC1 
exon/intron structure will reveal whether the second aber-
rantly sized transcript species is also derived from aberrant 
RNA processing. Our detection of these transcript species is 
consistent with previous findings by Zhu et al. [11] who dem-
onstrated alternative processing of another region of the hu-
man TRPC1 gene (omission of the nucleotides encoding ami-
no acids 102-143 of Htrp-1). 
In summary, we have demonstrated that transcripts from 
three currently known human TRPC genes are present in 
different human megakaryocyte cell lines. This is consistent 
with a potential role of TRPC proteins in Ca2+ homeostasis 
Fig. 3. Analysis of platelet cDNA using TRPC1-3 primers. Analysis 
was carried out using 40 cycles of PCR. (1-3) PCR with TRPC1-3 
primers; Ma, size marker (<|)X174/.r7aeIII); C, G3PDH cDNA (posi-
tive control). 
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in megakaryocytes and in blood platelets. That we were un-
able to detect mRNA derived from TRPC genes in platelets 
may reflect rapid processing of these transcripts after release 
of the cells into the circulation. Our findings are consistent 
with the notion that TRPCl is ubiquitously expressed albeit 
at tissue-specific levels. The presence of TRPC2 and TRPC3 
transcripts in megakaryocytes suggests that both genes, like 
TRPCl, may also be expressed in a variety of cell types, 
although the TRPC2 mRNA contains a premature stop co-
don and is therefore unlikely to produce a functional protein. 
Our study also suggests that the megakaryocytic cell lines may 
represent good model systems to study the role of TRPC 
proteins in agonist induced Ca2+ influx. 
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